Modelling long-term outcomes and risk of death for patients with post-stroke spasticity receiving abobotulinumtoxina treatment and rehabilitation therapy

CONCLUSION: AbobotulinumtoxinA + rehabilitation therapy may improve long-term outcomes, including post-stroke survival, while being cost-effective for the treatment of post-stroke spasticity.PMID:35844200 | DOI:10.2340/jrm.v54.2422

Source: Journal of Rehabilitation Medicine - July 18, 2022 Category: Rehabilitation Authors: Klemens Fheodoroff Natalya Danchenko John Whalen Jovita Balcaitiene Barbara Magalh ães Elzbieta Szulc Andrea Zaffalon Mariya Burchakova Dmitry Nechiporenko Sean Robbins Source Type: research